Aeglea BioTherapeutics, Inc. Insider Trading for December 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aeglea BioTherapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Aeglea BioTherapeutics, Inc. for December 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 08 2017 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | Interim CEO | Buy | P | 5.07 | 600 | 3,039 | 35,409 | 34.8 K to 35.4 K (+1.72 %) |
| Dec 08 2017 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | Interim CEO | Buy | P | 4.99 | 2,800 | 13,967 | 34,809 | 32 K to 34.8 K (+8.75 %) |
| Dec 08 2017 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | Interim CEO | Buy | P | 4.92 | 4,888 | 24,072 | 32,009 | 27.1 K to 32 K (+18.02 %) |
| Dec 05 2017 | AGLE | Aeglea BioTherapeu ... | York Charles N II | Chief Financial Off ... | Buy | P | 4.76 | 10,241 | 48,700 | 34,787 | 24.5 K to 34.8 K (+41.72 %) |
| Dec 05 2017 | AGLE | Aeglea BioTherapeu ... | York Charles N II | Chief Financial Off ... | Buy | P | 4.97 | 3,259 | 16,197 | 24,546 | 21.3 K to 24.5 K (+15.31 %) |
| Dec 05 2017 | AGLE | Aeglea BioTherapeu ... | York Charles N II | Chief Financial Off ... | Buy | P | 4.59 | 6,500 | 29,855 | 21,287 | 14.8 K to 21.3 K (+43.96 %) |
| Dec 05 2017 | AGLE | Aeglea BioTherapeu ... | York Charles N II | Chief Financial Off ... | Buy | P | 2.52 | 1,959 | 4,929 | 14,787 | 12.8 K to 14.8 K (+15.27 %) |
| Dec 05 2017 | AGLE | Aeglea BioTherapeu ... | York Charles N II | Chief Financial Off ... | Buy | P | 4.28 | 2,000 | 8,568 | 12,828 | 10.8 K to 12.8 K (+18.47 %) |
| Dec 05 2017 | AGLE | Aeglea BioTherapeu ... | York Charles N II | Chief Financial Off ... | Buy | P | 3.99 | 2,000 | 7,974 | 10,828 | 8.8 K to 10.8 K (+22.66 %) |
| Dec 05 2017 | AGLE | Aeglea BioTherapeu ... | Shanafelt Armen | Director | Option Exercise | A | 4.73 | 30,000 | 141,900 | 30,000 | |
| Dec 05 2017 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | Director | Buy | P | 4.93 | 5,065 | 24,976 | 27,121 | 22.1 K to 27.1 K (+22.96 %) |
| Dec 05 2017 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | Director | Buy | P | 4.98 | 7,956 | 39,624 | 22,056 | 14.1 K to 22.1 K (+56.43 %) |
| Dec 05 2017 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | Director | Buy | P | 4.53 | 4,100 | 18,578 | 14,100 | 10 K to 14.1 K (+41.00 %) |
| Dec 05 2017 | AGLE | Aeglea BioTherapeu ... | Mahatme Sandesh | Director | Option Exercise | A | 4.73 | 30,000 | 141,900 | 30,000 | |
| Dec 05 2017 | AGLE | Aeglea BioTherapeu ... | GEORGIOU GEORGE | Director | Option Exercise | A | 4.73 | 30,000 | 141,900 | 30,000 | |
| Dec 05 2017 | AGLE | Aeglea BioTherapeu ... | Cox Russell J. | Director | Option Exercise | A | 4.73 | 30,000 | 141,900 | 30,000 |